1Hoshino M, Takahashi M, Takai Y, et al. Inhaled corticosteroids decrease vascularity of the bronchial mucosa in patients with asthma. Clin Exp Allergy,2001,31:722-730.
2Orsida BE, Li X, Hickey B, et al. Vascularity in asthmatic airways: relation to inhaled steroid dose. Thorax, 1999,54:289-295.
3Chetta A, Zanini A, Foresi A, et al. Vascular component of airway remodeling in asthma is reduced by high dose of fluticasone. Am J Respir Crit Care Med,2003,167:751-757.
4Orsida BE, Ward C, Li X,et al. Effect of a long-acting beta2-agonist over three months on airway wall vascular remodeling in asthma. Am J Respir Crit Care Med,2001,164:117-121.
5Vanacker NJ, Palmans E, Kips JC, et al. Fluticasone inhibits but does not reverse allergen-induced structural airway changes. Am J Respir Crit Care Med,2001,163(3 Pt 1):674-679.
6Olivieri D, Chetta A, Del Donno M, et al. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. Am J Respir Crit Care Med,1997,155:1864-1871.
7Ward C, Pais M, Bish R,et al. Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax,2002,57:309-316.
8Shiels IA, Bowler SD, Taylor SM. The effects of salbutamol, beclomethasone, and dexamethasone on fibronectin expression by cultured airway smooth muscle cells. Inflammation,1999,23:321-331.
10Fernandes D, Guida E, Koutsoubos V, et al. Glucocorticoids inhibit proliferation, cyclin D1 expression, and retinoblastoma protein phosphorylation, but not activity of the extracellular-regulated kinases in human cultured airway smooth muscle. Am J Respir Cell Mol Biol, 1999,21:77-88.
二级参考文献1
1Marini M，Biochem Biophys Res Commun，1996年，220卷，896页
